Tirzepatide 60 mg — Lyophilized Vial 60 mg · 1 vial

What is Tirzepatide?

Tirzepatide is a synthetic peptide that activates GIP and GLP-1 receptors. These two incretin pathways participate in glucose regulation and metabolic signaling.

Biological activity

The molecule activates two incretin-receptor pathways involved in glucose-dependent insulin responses and metabolic regulation. Its dual activity distinguishes it from a GLP-1-only agent and from retatrutide's triple-receptor activity.

Purpose and areas of study

Researchers have investigated tirzepatide in glucose-control and body-weight studies. Early clinical proof-of-concept research measured metabolic responses to a defined investigational formulation.

Evidence context

GLP-2 is only the collection reference on this packaging, not the distinct hormone glucagon-like peptide 2. Findings for studied tirzepatide formulations do not establish equivalence of this vial.

Product presentation

One lyophilized vial. Labeled content: 60 mg.

Scientific references

PubMed 30473097; PubMed 35333651

Research-use information

All information on this page is provided for scientific education and research purposes only. This product is intended exclusively for laboratory research and is not for human or veterinary use. The information is not medical advice or a claim of therapeutic benefit.